People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Pharmaceuticals, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| InCarda Therapeutics, Inc. | — | Pharmaceuticals | Series B | $66.3M | $857.5M | 2017 |
| PerceptiMed, Inc. | — | Other Technology | Series A | $11.0M | $57.3M | 2014 |
| Paradigm Diagnostics, Inc. | — | Pharmaceuticals | Series A | $11.0M | $340.1M | 2016 |
| Cocoon Biotech Inc. | — | Biotechnology | Series A | $7.8M | $8.2M | 2017 |
Grace Colon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Grace Colon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rodney Markin | 2 | 4 |
| Somu Subramaniam | 1 | 17 |
| Isaac Cheng | 1 | 9 |
| John Friedman | 1 | 9 |
| Scott Morris | 1 | 8 |
| Annalisa Jenkins | 1 | 8 |
| Alan Colowick | 1 | 7 |
| Andrew ElBardissi | 1 | 7 |
| James Woody | 1 | 4 |
| TOM KING | 1 | 4 |
| John S. Patton | 1 | 3 |
| Johan Christenson | 1 | 3 |
| Jennifer Jacobs | 1 | 3 |
| Robert E. Curry | 1 | 2 |
| ALAN JACOBS | 1 | 2 |
| Grace E. Colon | 1 | 2 |
| David Neal | 1 | 2 |
| Carey Ng | 1 | 2 |
| Mary Thistle | 1 | 2 |
| Rangachari Narasimhan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.